WASHINGTON (Reuters)—U.S. President-elect Donald Trump aims to replace Obamacare with a plan that would envisage “insurance for everybody,” he said in an interview with the Washington Post published on Sunday night. Trump did not give the newspaper specifics about his proposals to replace Democratic President Barack Obama’s signature health insurance law, but said the plan…
AMA Updates Code of Medical Ethics
Eight years ago, the American Medical Association’s (AMA) Council on Ethical and Judicial Affairs embarked on a comprehensive review of the AMA Code of Medical Ethics. What emerged after years of hard effort, intensive feedback and thoughtful revisions was a modernized version of the guide, which the AMA House of Delegates voted to adopt in…
Stronger Malpractice Laws May Not Prevent Surgical Complications
(Reuters Health)—More aggressive malpractice climates don’t necessarily protect patients from surgical complications, a new study suggests. Supporters of medical malpractice laws that make it easier for patients to sue doctors say these protections are necessary to improve care. But in the current study, the risk of litigation didn’t translate into better outcomes, said study leader…
U.S. Senate to Act on Obamacare Repeal, McConnell Says
WASHINGTON (Reuters)—The U.S. Senate will take its first steps toward repealing President Barack Obama’s signature healthcare reform act by the end of the week, Senate Majority Leader Mitch McConnell (R-Ky.) said on Sunday. Speaking on CBS’s “Face the Nation,” McConnell said: “There ought not to be a great gap” between repealing the act and replacing…
Clinicians May Have Inaccurate Views of Benefits, Harms of Treatments & Tests
NEW YORK (Reuters Health)—Clinicians’ expectations of the benefits and harms of a wide range of treatments and tests are rarely accurate, according to a new study. “There was variation—with benefits and harms sometimes being overestimated and sometimes being underestimated; but there was a tendency for clinicians to more often underestimate (rather than overestimate) harms and…
Top ACR Priorities in 2017 Include Drug Costs, MACRA
With a new federal administration and Republican-controlled Congress taking the helm in 2017, the ACR Government Affairs Committee has identified top legislative and regulatory priorities for the year. “The main priority is going to be helping represent the rheumatology community as Medicare is reformed, because the era of MACRA started Jan. 1,” says Angus Worthing,…
Insurance Subcommittee to the Rescue
Concerned about reimbursement for specialty drugs? Wondering if your patient can continue on a prescribed medication despite formulary changes? Unsure how to request a tier exception? No need to face these issues alone. The ACR has a resource that can assist with questions regarding coverage and payment policies for private insurers and Medicare. That resource…
Chart a New Course: A Rheumatologist Talks about Practicing in an Orthopedic Environment
Working as a rheumatologist in an orthopedic practice has its own unique challenges, but may result in better patient care, according to Sheeja Francis, MD…
Considering an Investment in a Healthcare Tech Startup? 5 Tips
Investing in a healthcare tech startup can be tempting for rheumatologists looking for a change of pace. Here are a few insights on the risks and benefits of investing…
CMS Cancels Medicare Part B Demonstration Project
When the controversial Medicare Part B Drug Payment Model final rule was not released by the Centers for Medicare & Medicaid Services (CMS) as expected before Nov. 21, it signaled an increasing likelihood of defeat for the proposed rule—a signal proved true on Dec. 15. A spokesperson for the CMS said, “After considering comments, CMS…
- « Previous Page
- 1
- …
- 71
- 72
- 73
- 74
- 75
- …
- 149
- Next Page »